Skip to content

Evaluation of different nasal irrigation methods and solutions after surgery to correct a deviated septum and reduce nasal turbinates

Nasal Irrigation in the Postoperative Period Following Septoplasty and Partial Inferior Turbinectomy: A Randomized Clinical Trial on Devices and Solutions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4j37jfp
Enrollment
150
Registered
2026-06-15
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Turbinates

Interventions

This is a randomized, controlled, parallel-group clinical trial with single-blind outcome assessment. The study will include 150 adult participants undergoing septoplasty combined with partial inferio

Sponsors

Universidade Federal de São Paulo - UNIFESP/EPM
Lead Sponsor
Universidade Federal de São Paulo - UNIFESP/EPM
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Participants of both sexes, aged 18 to 60 years; diagnosis of nasal obstruction caused by nasal septal deviation associated with inferior turbinate hypertrophy; indication for septoplasty combined with partial inferior turbinectomy; provision of written informed consent through signing of the Informed Consent Form

Exclusion criteria

Exclusion criteria: Previous nasal and/or paranasal sinus surgery; other chronic sinonasal conditions, including chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps; current tobacco smoking; electronic cigarette use; cessation of tobacco smoking or electronic cigarette use within the previous six months; active infection at the time of surgery; pregnancy; breastfeeding; known allergy to any component of the irrigation solutions or devices used in the study; immunosuppression; autoimmune diseases; chronic use of systemic corticosteroids; reduced ability to detect sweet taste, defined as a score lower than 25 millimeters on a 0 to 100 millimeter Visual Analog Scale for sweetness intensity during the screening visit

Design outcomes

Primary

MeasureTime frame
Self-reported nasal obstruction assessed using a Visual Analog Scale (0–100 mm), recorded in a printed diary from postoperative day 1 (D1) to day 14 (D14), independently compared among different nasal irrigation devices and among different nasal irrigation solutions.

Secondary

MeasureTime frame
Evolution of other self-reported nasal symptoms (rhinorrhea, nasal dryness, and otalgia during irrigation), assessed daily using a 0–100 mm Visual Analog Scale in a printed diary from postoperative day 1 (D1) to day 14 (D14), compared between devices and between solutions; Adherence to the nasal irrigation regimen, measured by self-reported frequency in the printed diary, considering the number of irrigations performed daily between D1 and D14, evaluated between devices and between solutions; Endoscopic healing of the nasal cavities, measured using an endoscopic score applied at postoperative visits on D7 (±2 days) and D14 (±2 days), compared between devices and between solutions; Nasal mucociliary function, assessed using the saccharin test on postoperative day 14 (±2 days), compared between devices and between solutions; Time to clinically relevant improvement in self-reported nasal obstruction, defined as the first day on which the participant achieves a reduction greater than or equal to 12.5 mm on the Visual Analog Scale, compared between devices and between solutions; Acceptability of irrigation devices and solutions, assessed on D14 using a questionnaire adapted from the Theoretical Framework of Acceptability (TFA).

Countries

BR

Contacts

Public ContactIgor Batista

Universidade Federal de São Paulo - UNIFESP/EPM

igorbatistamd@yahoo.com.br+55(91)98416-3848

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 29, 2026